Changes in<i>HER2</i>Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and<sup>18</sup>F-Labeled Affibody MoleculesGabriela Krämer-Marek, Jacek Capala|Journal of Nuclear Medicine|2009Cited by 97
Targeted Radionuclide Therapy: Practical Applications and Future ProspectsKatherine Zukotynski, Frederic H. Fahey, Hossein Jadvar et al.|Biomarkers in Cancer|2016Cited by 50